Fulgent Genetics (FLGT) Non-Current Deferred Tax Liability (2016 - 2026)

Fulgent Genetics (FLGT) has 7 years of Non-Current Deferred Tax Liability data on file, last reported at $7.0 million in Q1 2026.

• Quarterly Non-Current Deferred Tax Liability rose 11.94% year-over-year to $7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.0 million (up 11.94% YoY) and the FY2025 annual result came in at $6.9 million, up 8.89% from the prior year.
• Non-Current Deferred Tax Liability climbed to $7.0 million in Q1 2026 per FLGT's latest filing, from $6.9 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $9.8 million in Q3 2023, with the low at $6.1 million in Q2 2025.
• Average Non-Current Deferred Tax Liability over 4 years is $7.1 million, with a median of $6.9 million recorded in 2024.
• Year-over-year, Non-Current Deferred Tax Liability sank 31.52% in 2024 and rose 11.94% in 2026.
• Fulgent Genetics' Non-Current Deferred Tax Liability stood at $8.0 million in 2023, then dropped by 19.99% to $6.4 million in 2024, then increased by 8.89% to $6.9 million in 2025, then climbed by 0.66% to $7.0 million in 2026.
• Business Quant data shows FLGT's Non-Current Deferred Tax Liability at $7.0 million in Q1 2026, $6.9 million in Q4 2025, and $7.0 million in Q3 2025.